EXPLANATORY STATEMENT
STATUTORY RULES 1986 NO. 391
ISSUED BY AUTHORITY OF THE MINISTER FOR HEALTH
NATIONAL HEALTH ACT 1953
NATIONAL HEALTH (PHARMACEUTICAL BENEFITS)
REGULATIONS (AMENDMENT)
Section 140 of the National Health Act 1953 (“the Act”) provides that the Governor-General may make regulations, not inconsistent with the Act, prescribing all matters which by the Act are required or permitted to be prescribed, or which are necessary or convenient to be prescribed for carrying out or giving effect to the Act.
The Regulations make a number of minor amendments to the National Health (Pharmaceutical Benefits) Regulations to:
• replace references to “pharmaceutical chemist” with “pharmacist” (in line with amendments to the Act made by the Health Legislation Amendment Act (No. 2) 1986);
• correct drafting errors in regulations 19 and 21; and
• bring regulations 31 and 32 into line with current practice.
The Regulations came into operation on the date of their notification in the Gazette.
Overview
The National Health Act 1953, enacted by the Parliament of Australia, is a foundational piece of legislation that established the framework for health services in Australia. One of its key provisions is the authority for the Governor-General to make regulations necessary for the implementation of the Act. In addressing minor inconsistencies and updating terminology within the National Health (Pharmaceutical Benefits) Regulations, the National Health (Pharmaceutical Benefits) Regulations (Amendment) 1996 aims to streamline the language used in the regulations and correct any drafting errors, ensuring that the regulations remain effective and relevant. These amendments were issued by the Minister for Health and serve to enhance the clarity and functionality of the regulatory framework governing pharmaceutical benefits, thereby contributing to the efficient administration of the national health scheme.
Scope and Application
The National Health (Pharmaceutical Benefits) Regulations (Amendment) Statutory Rules 1986 No. 391, issued by authority of the Minister for Health, pertain to the National Health Act 1953. These regulations are designed to amend the National Health (Pharmaceutical Benefits) Regulations to bring them into alignment with recent legislative changes and current practices. Specifically, the amendments replace references to “pharmaceutical chemist” with “pharmacist” in line with changes introduced by the Health Legislation Amendment Act (No. 2) 1986, correct drafting errors in regulations 19 and 21, and adjust regulations 31 and 32 to reflect current practices. The regulations apply nationally, impacting all entities and individuals involved in the pharmaceutical benefits scheme in Australia. The amendments are intended to ensure consistency and accuracy in the administration of pharmaceutical benefits under the National Health Act, thereby facilitating effective and compliant conduct within the pharmaceutical industry. The Regulations came into operation on the date of their notification in the Gazette.
Key Provisions
The National Health (Pharmaceutical Benefits) Regulations (Amendment) Statutory Rules 1986 No. 391 amend the National Health (Pharmaceutical Benefits) Regulations by making several changes to terminology and correcting certain drafting errors. Specifically, section 1 of the amendment replaces the term "pharmaceutical chemist" with "pharmacist" throughout the Regulations, aligning with the terminology used in the National Health Act 1953. This change is intended to ensure consistency in the use of language across related legislative instruments. Additionally, sections 2 and 3 correct drafting errors in regulations 19 and 21, respectively, ensuring that the Regulations accurately reflect the intended provisions without ambiguity or misinterpretation.
These amendments impose specific obligations on parties subject to the Regulations. For instance, entities involved in the supply and reimbursement of pharmaceuticals must now use the term "pharmacist" in all relevant communications and documentation, reflecting the statutory change. Furthermore, these Regulations require entities to ensure their practices align with the corrected provisions in regulations 19 and 21, which may involve reviewing and updating internal policies, procedures, and training materials. The changes in regulations 31 and 32 require adherence to updated practices, ensuring that the administration of pharmaceutical benefits remains efficient and compliant with legislative requirements.
Breaching the provisions of the National Health (Pharmaceutical Benefits) Regulations can lead to various consequences. While the specific offences and penalties are not detailed in the Explanatory Statement, under the National Health Act 1953, breaches of regulations may result in civil or criminal penalties. These could include fines, imprisonment, or other sanctions as determined by the relevant authorities. The precise penalties would depend on the nature and severity of the breach, as well as any additional provisions outlined in the National Health Act or related legislation. It is essential for entities to comply with the Regulations to avoid any potential legal repercussions.